MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 167 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2014. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,894,000 | +75.2% | 107,579 | +72.8% | 0.39% | +177.3% |
| Q4 2018 | $1,081,000 | -43.0% | 62,248 | -51.1% | 0.14% | -31.6% |
| Q3 2018 | $1,897,000 | -33.5% | 127,333 | -29.1% | 0.21% | -15.9% |
| Q2 2018 | $2,854,000 | +24.6% | 179,505 | +10.3% | 0.24% | +30.3% |
| Q1 2018 | $2,291,000 | +58.8% | 162,778 | +57.9% | 0.19% | +229.8% |
| Q4 2017 | $1,443,000 | +27.9% | 103,058 | +30.7% | 0.06% | -46.7% |
| Q3 2017 | $1,128,000 | -5.5% | 78,877 | +4.0% | 0.11% | -0.9% |
| Q2 2017 | $1,194,000 | +87.4% | 75,830 | +145.5% | 0.11% | +24.1% |
| Q1 2016 | $637,000 | +154.8% | 30,894 | +153.1% | 0.09% | +22.5% |
| Q4 2015 | $250,000 | +5.0% | 12,205 | -4.5% | 0.07% | -16.5% |
| Q2 2015 | $238,000 | -62.6% | 12,785 | -66.9% | 0.08% | -68.0% |
| Q4 2014 | $636,000 | -15.6% | 38,638 | -9.4% | 0.27% | -37.9% |
| Q3 2014 | $754,000 | +57.1% | 42,639 | +93.7% | 0.43% | +81.4% |
| Q1 2014 | $480,000 | – | 22,009 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |